View Financial HealthEMS-CHEMIE HOLDING 배당 및 자사주 매입배당 기준 점검 3/6EMS-CHEMIE HOLDING 수익으로 충분히 충당되는 현재 수익률 2.62% 보유한 배당금 지급 회사입니다.핵심 정보2.6%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률3.0%배당 성장률1.9%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향73%최근 배당 및 자사주 매입 업데이트공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • Jun 09Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €775. The fair value is estimated to be €645, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.7% over the last 3 years. Earnings per share has declined by 3.7%. For the next 3 years, revenue is forecast to grow by 2.5% per annum. Earnings are also forecast to grow by 4.7% per annum over the same time period.Buy Or Sell Opportunity • May 22Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to €765. The fair value is estimated to be €633, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.7% over the last 3 years. Earnings per share has declined by 3.7%. For the next 3 years, revenue is forecast to grow by 2.6% per annum. Earnings are also forecast to grow by 4.5% per annum over the same time period.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buy Or Sell Opportunity • Feb 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €690. The fair value is estimated to be €569, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.8% over the last 3 years. Earnings per share has declined by 3.6%. For the next 3 years, revenue is forecast to grow by 3.4% per annum. Earnings are also forecast to grow by 4.9% per annum over the same time period.Reported Earnings • Feb 08Full year 2025 earnings released: EPS: CHF19.97 (vs CHF19.70 in FY 2024)Full year 2025 results: EPS: CHF19.97 (up from CHF19.70 in FY 2024). Revenue: CHF1.95b (down 6.7% from FY 2024). Net income: CHF467.0m (up 1.3% from FY 2024). Profit margin: 24% (up from 22% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Chemicals industry in Italy.공시 • Feb 05+ 1 more updateEMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Final Results on Jul 10, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 final results on Jul 10, 2026Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jan 06EMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Results on Feb 06, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 results on Feb 06, 2026Board Change • Sep 12Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Aug 08Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jul 15EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025, at 10:30 W. Europe Standard Time.공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 배당금 지급이 안정적인 반면, 1EMSN 은(는) 배당금을 지급한 지 10년도 채 되지 않았습니다.배당금 증가: 1EMSN 의 배당금 지급이 증가했지만 회사는 9 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장EMS-CHEMIE HOLDING 배당 수익률 vs 시장1EMSN의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (1EMSN)2.6%시장 하위 25% (IT)1.5%시장 상위 25% (IT)4.6%업계 평균 (Chemicals)3.3%분석가 예측 (1EMSN) (최대 3년)3.0%주목할만한 배당금: 1EMSN 의 배당금( 2.62% )은 Italian 시장에서 배당금 지급자의 하위 25%( 1.55% )보다 높습니다.고배당: 1EMSN 의 배당금( 2.62% )은 Italian 시장에서 배당금 지급자의 상위 25%( 4.57% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적인 지급 비율 ( 73.5% )을 통해 1EMSN 의 배당금 지급은 수익으로 충당됩니다.주주 현금 배당현금 흐름 범위: 현재 현금 지급 비율 ( 85.1% )에서 1EMSN 의 배당금 지급은 현금 흐름으로 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIT 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/15 11:38종가2026/06/15 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스EMS-CHEMIE HOLDING AG는 14명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchAdrien TamagnoBerenberg11명의 분석가 더 보기
공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.
Buy Or Sell Opportunity • Jun 09Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €775. The fair value is estimated to be €645, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.7% over the last 3 years. Earnings per share has declined by 3.7%. For the next 3 years, revenue is forecast to grow by 2.5% per annum. Earnings are also forecast to grow by 4.7% per annum over the same time period.
Buy Or Sell Opportunity • May 22Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to €765. The fair value is estimated to be €633, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.7% over the last 3 years. Earnings per share has declined by 3.7%. For the next 3 years, revenue is forecast to grow by 2.6% per annum. Earnings are also forecast to grow by 4.5% per annum over the same time period.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buy Or Sell Opportunity • Feb 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 15% to €690. The fair value is estimated to be €569, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.8% over the last 3 years. Earnings per share has declined by 3.6%. For the next 3 years, revenue is forecast to grow by 3.4% per annum. Earnings are also forecast to grow by 4.9% per annum over the same time period.
Reported Earnings • Feb 08Full year 2025 earnings released: EPS: CHF19.97 (vs CHF19.70 in FY 2024)Full year 2025 results: EPS: CHF19.97 (up from CHF19.70 in FY 2024). Revenue: CHF1.95b (down 6.7% from FY 2024). Net income: CHF467.0m (up 1.3% from FY 2024). Profit margin: 24% (up from 22% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Chemicals industry in Italy.
공시 • Feb 05+ 1 more updateEMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Final Results on Jul 10, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 final results on Jul 10, 2026
Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jan 06EMS-CHEMIE HOLDING AG to Report Fiscal Year 2025 Results on Feb 06, 2026EMS-CHEMIE HOLDING AG announced that they will report fiscal year 2025 results on Feb 06, 2026
Board Change • Sep 12Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Aug 08Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman of the Board Bernhard Merki was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jul 15EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025EMS-CHEMIE HOLDING AG, Annual General Meeting, Aug 09, 2025, at 10:30 W. Europe Standard Time.
공시 • Jul 13EMS-CHEMIE HOLDING AG announces Annual dividend, payable on August 14, 2025EMS-CHEMIE HOLDING AG announced Annual dividend of CHF 13.9500 per share payable on August 14, 2025, ex-date on August 12, 2025 and record date on August 13, 2025.